A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma-Reference-Cited by-同舟云学术

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

Published:2006 Issue:12 Volume:54 Page:3962-3970
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Hoyles Rachel K.,Ellis Ross W.,Wellsbury Jessica,Lees Belinda,Newlands Pauline,Goh Nicole S. L.,Roberts Christopher,Desai Sujal,Herrick Ariane L.,McHugh Neil J.,Foley Noeleen M.,Pearson Stanley B.,Emery Paul,Veale Douglas J.,Denton Christopher P.,Wells Athol U.,Black Carol M.,du Bois Roland M.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference36 articles.

1. Sentinel signs and symptoms of systemic sclerosis

2. Pulmonary Function in Progressive Systemic Sclerosis

3. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.

4. Alveolar macrophages from systemic sclerosis patients: evidence for IL-4-mediated phenotype changes

5. Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium

Cited by 612 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of interstitial lung disease in systemic sclerosis: guidelines and new clinical trial results;Current Opinion in Rheumatology;2024-08-28

2. Lung Involvement in Systemic Sclerosis—From Pathogenesis to Prediction;Sclerosis;2024-08-17

3. Real-World Clinical Profile and Safety of Nintedanib in Systemic Sclerosis-Associated Interstitial Lung Disease: A Subgroup Analysis of Interstitial Lung Disease Data From an Interstitial Lung Disease (ILD) Specialty Clinic in India;Cureus;2024-07-28

4. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases;Arthritis & Rheumatology;2024-07-08

5. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases;Arthritis Care & Research;2024-07-08